Knowledge, Attitude, and Practice of Metformin Extended-Release Tablets Among Clinicians in China: A Cross-Sectional Survey
Background: Metformin extended-release (XR) is a once-daily alternative conventional immediate-release (IR) tablet for adults with type 2 diabetes.Aim: This study aimed to investigate the knowledge, attitude, and practice of the use of metformin XR tablets among clinicians.Methods: We conducted a cr...
Main Authors: | Chang Liu, Siqi Tang, Kang An, Shengzhao Zhang, Yiling Zhou, Na Su, Rong Yang, Xiaoyang Liao, Zhenmei An, Sheyu Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.634561/full |
Similar Items
-
Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review
by: Jixue Tan, et al.
Published: (2021-05-01) -
Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes
by: Derosa G, et al.
Published: (2017-05-01) -
METFORMIN: FROM IMMEDIATE RELEASE TO EXTENDED RELEASE FORMULA, EFFECTIVENESS, AND SAFETY IN PATIENTS WITH CHRONIC KIDNEY DISEASE
by: Giuseppe Derosa, et al.
Published: (2020-11-01) -
Metformin in Patients With COVID-19: A Systematic Review and Meta-Analysis
by: Yin Li, et al.
Published: (2021-08-01) -
Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects
by: Rhee SJ, et al.
Published: (2016-04-01)